SYRE Stock Analysis: Buy, Sell, or Hold?
SYRE - Spyre Therapeutics, Inc. Common Stock
$98.85
-1.47 (-1.47%)
▼
5d:
+18.27%
30d:
+33.01%
90d:
+131.17%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When SYRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SYRE is 15.1% above its trading range ($85.89). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SYRE is 15.1% above its trading range ($85.89). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SYRE is currently trading at $98.85, which is considered extended relative to its 30-day fair value range of $69.22 to $85.89.
Technical Outlook: Technically, SYRE is in a strong uptrend. The price is approaching resistance at $100.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SYRE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SYRE is in a strong uptrend. The price is approaching resistance at $100.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SYRE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$69.22 -
$85.89
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+15.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($99.13)
- WARNING: Recommendation downgraded due to 15.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$69.22 -
$85.89
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$70.89
Resistance Level
$100.40
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-32.17
Wall Street Target
$99.13
(-1.2%)
Earnings Growth (YoY)
-99.7%
Share & Embed Analysis
Last updated: June 23, 2026 12:03 PM ET
Data refreshes hourly during market hours. Next update: 1:03 PM
Data refreshes hourly during market hours. Next update: 1:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Cameron Turtle
SELL
15000 shares
2026-04-01
Scott L Burrows
SELL
7500 shares
2026-04-01
Sheldon Sloan
SELL
7958 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 66 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 65 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 59 HOLD |
